Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 700 of 771 entries
View as:

Salt-Sensitivity and Immunity Cell Activation

Phase: N/A Priority: Normal
NCT ID: NCT03753204 Org: User:
Start: 09/01/21 End: 09/15/25 Due: 09/15/26

Epidemiology of Silent and Overt Strokes in Sickle Cell Disease

Phase: N/A Priority: Normal
NCT ID: NCT03376893 Org: User:
Start: 06/02/17 End: 12/31/26 Due: 12/31/27

Pharmacological Modulation of Hippocampal Activity in Psychosis 2

Phase: N/A Priority: Normal
NCT ID: NCT04559529 Org: User:
Start: 09/23/20 End: 12/31/23 Due: 12/31/24

Tranexamic Acid in Rhinoplasty: Perioperative Bleeding, Edema and Ecchymosis

Phase: N/A Priority: Normal
NCT ID: NCT05774717 Org: User:
Start: 04/01/23 End: 02/01/26 Due: 02/01/27

Quantitation of Glymphatic Functioning in Sleep and Meditative States

Phase: N/A Priority: Normal
NCT ID: NCT04506892 Org: User:
Start: 02/01/21 End: 07/31/27 Due: 07/31/28

Observation Versus Immediate Surgery of Low Risk Bladder Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02700724 Org: User:
Start: 04/30/16 End: 07/19/18 Due: 07/19/19

Continuation of Antiarrhythmics Following Ventricular Tachycardia Catheter Ablation

Phase: N/A Priority: Normal
NCT ID: NCT04208997 Org: User:
Start: 12/19/19 End: 06/30/21 Due: 06/30/22

Use of Insulin Glargine to Treat Diabetic Ketoacidosis

Phase: N/A Priority: Normal
NCT ID: NCT00179127 Org: User:
Start: 08/31/04 End: 09/30/12 Due: 09/30/13

Telehealth Mindfulness After Spine Surgery

Phase: N/A Priority: Normal
NCT ID: NCT05698914 Org: User:
Start: 02/22/23 End: 07/31/25 Due: 07/31/26

Hemodialysis.-Induced Hypotension Therapy for End Stage Kidney Disease

Phase: N/A Priority: Normal
NCT ID: NCT05297786 Org: User:
Start: 07/27/22 End: 02/28/25 Due: 02/28/26

Computerized Memory Enhancing Treatment in MCI

Phase: N/A Priority: Normal
NCT ID: NCT05332522 Org: User:
Start: 08/09/22 End: 12/31/24 Due: 12/31/25

Assessment of Duodenal Epithelial Integrity in Celiac Disease With Mucosal Impedance

Phase: N/A Priority: Normal
NCT ID: NCT03152279 Org: User:
Start: 12/31/16 End: 11/14/18 Due: 11/14/19

Tissue Growth Characterization for Cochlear Implant Users

Phase: N/A Priority: Normal
NCT ID: NCT04320251 Org: User:
Start: 06/15/25 End: 01/09/26 Due: 01/09/27

Empiric Versus Selective Prevention Strategies for Kidney Stone Disease

Phase: N/A Priority: Normal
NCT ID: NCT05365477 Org: User:
Start: 08/04/22 End: 03/31/26 Due: 03/31/27

Obesity Surgery and Kidney Transplant for Patients With Obesity and Renal Failure

Phase: N/A Priority: Normal
NCT ID: NCT02128802 Org: User:
Start: 04/01/14 End: 03/28/24 Due: 03/28/25

Efficacy of a Mechanical Chair for Treatment of Benign Paroxysmal Positional Vertigo (BPPV)

Phase: N/A Priority: Normal
NCT ID: NCT03161470 Org: User:
Start: 06/08/17 End: 09/05/20 Due: 09/05/21

Use of MRI and CTBS for Catatonia in Autism

Phase: N/A Priority: Normal
NCT ID: NCT06016764 Org: User:
Start: 08/23/23 End: 08/23/26 Due: 08/23/27

Study of the Loss of AV Synchrony at Maximum Exercise

Phase: N/A Priority: Normal
NCT ID: NCT03859167 Org: User:
Start: 09/10/19 End: 04/10/23 Due: 04/10/24

Phase 2 Study of Montelukast for the Treatment of Sickle Cell Anemia

Phase: N/A Priority: Normal
NCT ID: NCT01960413 Org: User:
Start: 11/30/13 End: 03/31/18 Due: 03/31/19

Prevention of Malnutrition in Children with Sickle Cell Disease

Phase: N/A Priority: Normal
NCT ID: NCT06397118 Org: User:
Start: 11/06/24 End: 05/31/27 Due: 05/31/28

Theophylline as a Treatment for Children With Pseudohypoparathyroidism Type 1a (Albright Hereditary Osteodystrophy)

Phase: N/A Priority: Normal
NCT ID: NCT02463409 Org: User:
Start: 06/30/15 End: 10/31/16 Due: 10/31/17

Evaluating the Pre-Positioning Frame for Robotic Acoustic Neuroma Removal Surgery

Phase: N/A Priority: Normal
NCT ID: NCT03057678 Org: User:
Start: 12/31/21 End: 12/31/21 Due: 12/31/22

AI-driven Clinical Decision Support to Reduce Hospital-Acquired Venous Thromboembolism: Study Protocol for the VTE-AI Randomized Trial.

Phase: N/A Priority: Normal
NCT ID: NCT06939803 Org: User:
Start: 06/01/25 End: 12/31/26 Due: 12/31/27

An Analysis of Urinary Proteases as Biomarkers for Hepatocellular Carcinoma-101423

Phase: N/A Priority: Normal
NCT ID: NCT01316679 Org: User:
Start: 03/31/11 End: 01/31/13 Due: 01/31/14

A Trial for Prevention of Recurrent Ischemic Priapism in Men With Sickle Cell Disease: A Pilot Study

Phase: N/A Priority: Normal
NCT ID: NCT05142254 Org: User:
Start: 04/01/22 End: 11/09/23 Due: 11/09/24